4450711000001107: Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\UK product\Virtual medicinal product\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\UK product\Virtual therapeutic moiety\Nevirapine\Product containing only nevirapine in oral dose form (medicinal product form)\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\UK product\Virtual therapeutic moiety\Nevirapine\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\UK product\Trade family\Viramune\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing nevirapine\Nevirapine\Product containing only nevirapine in oral dose form (medicinal product form)\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing nevirapine\Nevirapine\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing reverse transcriptase inhibitor\Product containing nevirapine\Product containing nevirapine in oral dose form (medicinal product form)\Product containing only nevirapine in oral dose form (medicinal product form)\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with cyclopropane structure (product)\Product containing nevirapine\Nevirapine\Product containing only nevirapine in oral dose form (medicinal product form)\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with cyclopropane structure (product)\Product containing nevirapine\Nevirapine\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing substance with cyclopropane structure (product)\Product containing nevirapine\Product containing nevirapine in oral dose form (medicinal product form)\Product containing only nevirapine in oral dose form (medicinal product form)\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing nevirapine\Nevirapine\Product containing only nevirapine in oral dose form (medicinal product form)\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing nevirapine\Nevirapine\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing nevirapine\Product containing nevirapine in oral dose form (medicinal product form)\Product containing only nevirapine in oral dose form (medicinal product form)\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing nevirapine in oral dose form (medicinal product form)\Product containing only nevirapine in oral dose form (medicinal product form)\Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension\Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

18122501000001116 Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

18122601000001117 Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Is a	Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has excipient	Paraben and/or paraben derivative	false	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has active ingredient	Nevirapine	false	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has active ingredient	Nevirapine hemihydrate	false	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has manufactured dose form	Conventional release oral suspension	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Is a	Viramune	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has excipient	Hydroxybenzoates	false	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Nevirapine	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has specific active ingredient	Nevirapine hemihydrate	false	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has dispensed dose form	Conventional release oral suspension	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has specific active ingredient	Nevirapine hemihydrate	true	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Has basis of strength substance	Nevirapine	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) 240 ml	Is pack of	False	Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Inferred relationship	Existential restriction modifier
Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) 240 ml	Has AMP	True	Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
18122501000001116	Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
18122601000001117	Viramune 50mg/5ml oral suspension (Boehringer Ingelheim Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module